


Ask a doctor about a prescription for PALIPERIDONE SANDOZ 6 mg PROLONGED-RELEASE TABLETS
Package Leaflet: Information for the Patient
Paliperidona Sandoz 3 mg prolonged-release tablets EFG
Paliperidona Sandoz 6 mg prolonged-release tablets EFG
Paliperidona Sandoz 9 mg prolonged-release tablets EFG
Read the entire package leaflet carefully before you start taking this medicine, as it contains important information for you.
Contents of the package leaflet
Paliperidona Sandoz contains the active substance paliperidone, which belongs to a class of medicines called antipsychotics.
Paliperidone is used to treat schizophrenia in adults and adolescents aged 15 years and older.
Schizophrenia is a disorder that causes symptoms such as hearing, seeing, or feeling things that do not exist, having false beliefs, being abnormally suspicious, being withdrawn, having disorganized speech, and a flattening of emotions and behavior. People with this disorder may also feel depressed, anxious, guilty, or tense.
Paliperidone is also used to treat schizoaffective disorder in adults.
Schizoaffective disorder is a mental health condition where a person experiences several symptoms of schizophrenia (listed in the previous paragraph) in addition to symptoms of mood disorder (feeling euphoric, sad, agitated, restless, insomnia, talkativeness, loss of interest in daily activities, excessive or reduced sleep or food intake, and recurring thoughts of suicide).
Paliperidone can help alleviate the symptoms of your illness and prevent them from coming back.
Do not takePaliperidona Sandoz
Warnings andprecautions
Talk to your doctor, pharmacist, or nurse before starting to take paliperidone.
You should know that these two disorders can be caused by this type of medicine.
If you have any of these diseases, please consult your doctor, as it may be necessary to adjust your dose or keep you under observation for a while.
Because it has been very rarely observed in patients treated with paliperidone that a dangerously low number of a type of white blood cells necessary to fight infections in the blood, your doctor may check the number of white blood cells.
Paliperidone may cause you to gain weight. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.
In patients treated with paliperidone, diabetes mellitus or worsening of pre-existing diabetes mellitus has been observed, and your doctor should check for signs of increased blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.
During eye surgery for cataracts, the pupil (the black circle in the middle of the eye) may not increase in size as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery, which can cause eye damage. If you are considering eye surgery, make sure to inform your ophthalmologist that you are using this medicine.
Children andadolescents
Paliperidone should not be given to children and adolescents under 15 years of age for the treatment of schizophrenia.
Paliperidone should not be given to children and adolescents under 18 years of age for the treatment of schizoaffective disorder.
This is because it is not known if paliperidone is safe or effective in this age group.
Other medicines andPaliperidona Sandoz
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Abnormalities in heart function may appear when taking this medicine with other medicines for controlling heart rhythm or other medicines such as antihistamines, antimalarials, or antipsychotics.
Since this medicine acts mainly on the brain, it may interfere with other medicines (or alcohol) that also act on it, due to the sum of effects on brain function.
This medicine may lower blood pressure, so be careful if you take this medicine with other medicines that also lower blood pressure.
This medicine may reduce the effect of medicines for Parkinson's disease and restless legs syndrome (e.g., levodopa).
The effects of this medicine may be affected if you take medicines that influence the speed of intestinal movement (e.g., metoclopramide).
A reduction in the dose of this medicine should be considered when administered with valproate.
The use of oral risperidone with this medicine is not recommended, as this combination may cause an increase in side effects.
Paliperidone should be used with caution with medicines that increase the activity of the central nervous system (psychostimulants such as methylphenidate).
Taking Paliperidona Sandoz withalcohol
You should avoid consuming alcohol during treatment with this medicine.
Pregnancy andbreast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not take this medicine during pregnancy unless you have discussed it with your doctor.
The following symptoms may occur in newborn babies of mothers who have been treated with paliperidone in the last trimester of pregnancy (the last three months of pregnancy): trembling, stiffness, and/or muscle weakness, drowsiness, agitation, breathing problems, and feeding difficulties. If your baby develops any of these symptoms, you should contact your doctor.
You should not breast-feed while taking this medicine.
Driving and usingmachines
During treatment with this medicine, dizziness and vision problems may appear (see section 4, Possible side effects). This should be taken into account when requiring maximum attention, e.g., when driving or using machinery.
Paliperidona Sandoz contains sodium
This medicine contains 15.74 mg of sodium (a major component of cooking/table salt) in each prolonged-release tablet. This is equivalent to 0.79% of the maximum recommended daily intake of sodium for an adult.
Follow exactly the administration instructions of this medicine given by your doctor, pharmacist, or nurse.
Use inadults
The recommended dose in adults is 6 mg once a day in the morning. Your doctor may increase or decrease it within the dosage range of 3 mg to 12 mg once a day in case of schizophrenia or 6 mg to 12 mg once a day in case of schizoaffective disorder. This depends on how well the medicine works for you.
Use inadolescents
The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years and older is 3 mg once a day taken in the morning.
For adolescents who weigh 51 kg or more, the dose may be increased within the range of 6 mg to 12 mg once a day.
For adolescents who weigh less than 51 kg, the dose may be increased to 6 mg once a day.
Your doctor will decide how much you should take. The amount you take depends on how well the medicine works for you.
How and when to take Paliperidona Sandoz
This medicine should be taken by mouth, swallowed whole with water or other liquids. It should not be chewed, broken, or crushed.
This medicine should be taken in the morning with breakfast or on an empty stomach, but in the same way every day. Do not alternate between taking the medicine one day with breakfast and the next day on an empty stomach.
The active substance, paliperidone, is released once swallowed, and the tablet coating is eliminated from the body through the feces.
Patient withkidney problems
Your doctor may adjust the dose of this medicine according to your kidney function.
Elderly patients
Your doctor may reduce your dose of medicine if your kidney function is reduced.
If you take more Paliperidona Sandoz than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
You may experience drowsiness, fatigue, abnormal body movements, problems standing and walking, dizziness due to decreased blood pressure, and changes in heart rhythm.
If you forget to take Paliperidona Sandoz
Do not take a double dose to make up for forgotten doses. If you forget a dose, take the next dose the next day. If you forget two or more doses, contact your doctor.
If you stop taking Paliperidona Sandoz
Do not stop taking this medicine, as you will lose the effects of the medicine. Do not stop taking this medicine unless your doctor tells you to, as your symptoms may come back.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Report immediately to your doctorif:
Very Common Adverse Effects: may affect more than 1 in 10 patients
Common Adverse Effects: may affect up to 1 in 10 patients
Uncommon Adverse Effects: may affect up to 1 in 100 patients
Rare Adverse Effects: may affect up to 1 in 1,000 patients
Adverse Effects of Unknown Frequency: cannot be estimated from the available data
The following adverse effects have appeared with the use of another medicine called risperidone, which is very similar to paliperidone, so it is also expected to appear with paliperidone: sleep-related eating disorder, other types of cerebral vascular problems, lung crackling sounds, and severe or fatal skin rash with blisters and peeling that can start around the mouth, nose, eyes, genitals, and spread to other areas of the body (Stevens-Johnson Syndrome or toxic epidermal necrolysis). Eye problems may also occur during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken paliperidone. If you need to undergo cataract surgery, make sure to inform your ophthalmologist if you are taking or have taken this medicine.
Additional Adverse Effects in Adolescents
Adolescents generally presented similar adverse effects to those found in adults, except for the following adverse effects that were detected more frequently:
Reporting of Adverse Effects
If you experience adverse effects, consult your doctor, pharmacist, or nurse, even if they are adverse effects that do not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and on the carton after CAD/EXP. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Paliperidona Sandoz
Paliperidona Sandoz 3 mg prolonged-release tablets.
Each tablet contains 3 mg of paliperidone.
Paliperidona Sandoz 6 mg prolonged-release tablets
Each tablet contains 6 mg of paliperidone.
Paliperidona Sandoz 9 mg prolonged-release tablets
Each tablet contains 9 mg of paliperidone.
Core of the tablet
Macrogol 200000
Macrogol 7000000
Butylhydroxytoluene (E 321)
Povidone K30
Sodium chloride
Microcrystalline cellulose
Magnesium stearate
Red iron oxide (E 172)
Hydroxypropyl cellulose
Coating
(3 mg, 6 mg, 9 mg)
Cellulose acetate
Macrogol 4000
Hypromellose 6cP
Titanium dioxide (E 171)
Talc
Propylene glycol
(6 mg)
Yellow iron oxide (E 172)
(9 mg)
Red iron oxide (E 172)
Printing ink
Lacquer
Black iron oxide (E 172)
Propylene glycol
Appearance of the Product and Package Contents
Paliperidona Sandoz 3 mg are white to grayish-white, round, biconvex prolonged-release tablets with a possible irregular surface, marked with P3 on one side.
Paliperidona Sandoz 6 mg are yellowish-brown, round, biconvex prolonged-release tablets with a possible irregular surface, marked with P6 on one side.
Paliperidona Sandoz 9 mg are pink, round, biconvex prolonged-release tablets with a possible irregular surface, marked with P9 on one side.
The prolonged-release tablets are packaged in single-dose blisters of OPA/AL/PVC/Aluminum and inside a cardboard box.
Package sizes: 14x1, 28x1, 30x1, 49x1, 56x1, and 98x1 prolonged-release tablets.
Not all package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
or
Lek Pharmaceuticals d.d.
Verovškova 57
SLO-1526 Ljubljana
Slovenia
Date of the Last Revision of this Leaflet:March 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of PALIPERIDONE SANDOZ 6 mg PROLONGED-RELEASE TABLETS in December, 2025 is around 55.17 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for PALIPERIDONE SANDOZ 6 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.